R. I. Nooter

Amphia Ziekenhuis

Papers

1

Total Citations

8

H-Index

1

About

R. I. Nooter is a leading urological oncologist whose research focuses on optimizing surgical outcomes for bladder cancer, particularly through comparative effectiveness studies of robot-assisted versus open radical cystectomy. Their most impactful work, an intermediate-term survival analysis of these surgical approaches in the Netherlands, has garnered significant attention with 8 citations, providing critical real-world evidence that robot-assisted radical cystectomy (RARC) offers non-inferior oncological outcomes compared to open surgery for muscle-invasive and high-risk non-muscle invasive bladder cancer. This contribution is pivotal in guiding clinical decision-making, as it addresses the longstanding debate over surgical technique efficacy. Nooter’s research is instrumental in advancing minimally invasive urologic oncology, demonstrating that RARC can achieve comparable survival rates while potentially reducing perioperative morbidity. Their work has shaped national treatment protocols and informed surgical practice, highlighting their role as a key figure in evidence-based urology. Through rigorous population-based studies, Nooter continues to influence the evolution of bladder cancer management, bridging the gap between surgical innovation and patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 51
🏛 Institutions: Amphia Ziekenhuis

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago